Sjögren's syndrome myelopathy: Spinal cord involvement in Sjögren's syndrome might be a manifestation of neuromyelitis optica

Multiple Sclerosis

Volumn 15, Issue 9, 2009, Pages 1062-1068

  Kim, S M ^a   Waters, P ^b   Vincent, A ^b   Kim, S Y ^a   Kim, H J ^a   Hong, Y H ^c   Park, K S ^a   Min, J H ^d   Sung, J J ^a   Lee, K W ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Seoul National University Boramae Hospital   (South Korea)

^d Catholic Kwandong University   (South Korea)

Author keywords

AQP 4; Myelopathy; Neuromyelitis optica; Relapse remitting; Sj gren; Spinal cord

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; METHOTREXATE; STEROID; UNCLASSIFIED DRUG; AQP4 PROTEIN, HUMAN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOPRECIPITATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LEUKOARAIOSIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; PLEOCYTOSIS; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RECURRENCE RISK; SJOEGREN SYNDROME; SPINAL CORD DISEASE; BRAIN; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MYELIN SHEATH; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPINAL CORD;

ADULT; AGE OF ONSET; AQUAPORIN 4; BRAIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYELIN SHEATH; NEUROMYELITIS OPTICA; RECURRENCE; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; SPINAL CORD; STEROIDS;

EID: 69149091204     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509106636     Document Type: Article

References (16)

1. Vitali, C, Bombardieri, S, Jonsson, R, et al. Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
2. Delalande, S, de Seze, J, Fauchais, AL, et al. Neurologic manifestations in primary Sjogren syndrome: A study of 82 patients. Medicine (Baltimore) 2004; 83: 280-291.
3. Pericot, I, Brieva, L, Tintore, M, Rio, J, Sastre-Garriga, J, Montalban, C. Myelopathy in seronegative Sjogren syndrome and/or primary progressive multiple sclerosis. Mult Scler 2003; 9: 256-259.
4. Waters, P, Jarius, S, Littleton, E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally-extensive transverse myelitis. Arch Neurol 2008; 65: 913-919.
5. Wingerchuk, DM, Lennon, VA, Pittock, SJ, Lucchinetti, CF, Weinshenker, BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
6. Pittock, SJ, Lennon, VA, de Seze, J, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008; 65: 78-83.
7. Hayakawa, S, Mori, M, Okuta, A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008; 196: 181-187.
8. Arabshahi, B, Pollock, AN, Sherry, DD, Albert, DA, Kreiger, PA, Pessler, F. Devic disease in a child with primary Sjögren syndrome. J Child Neurol 2006; 21: 285-286.
9. Pantoni, L, Garcia, JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: A review. Stroke 1995; 26: 1293-1301.
10. Pittock, S, Weinshenker, B, Lucchinetti, C,Wingerchuk, D, Corboy, J, Lennon, V. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63: 964-968.
11. Pittock, S, Lennon, V, Krecke, K, Wingerchuk, D, Lucchinetti, C, Weinshenker, B. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.
12. Jacob, A, Matiello, M, Wingerchuk, D, Lucchinetti, C, Pittock, S, Weinshenker, B. Neuromyelitis optica: Changing concepts. J Neuroimmunol 2007; 187: 126-138.
13. Williams, CS, Butler, E, Román, GC. Treatment of myelopathy in Sjogren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 2001; 58: 815-819.
14. Yamout, B, El-Hajj, T, Barada, W, Uthman, I. Successful treatment of refractory neuroSjogren with Rituximab. Lupus 2007; 16: 521-523.
15. Wingerchuk, DM, Hogancamp, WF, O'Brien, PC, Weinshenker, BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
16. Steinfeld, S, Cogan, E, King, LS, Agre, P, Kiss, R, Delporte, C. Abnormal distribution of aquaporin-5 water channel protein in salivary gland from Sjogren's syndrome. Lancet 2001; 357: 688-689.